From Seattletimes · · 1m 10s
Court approves $7.25 billion Bayer settlement for Roundup cancer claims
Bayer agrees to $7.25 billion settlement with cancer patients over Roundup weedkiller claims.
In brief
Bayer agrees to $7.25 billion settlement with cancer patients over Roundup weedkiller claims. Bayer will pay up to $7.25 billion to resolve cancer claims from Roundup users, including those with non-Hodgkin lymphoma. Originally reported by Seattletimes.
Court approves $7.25 billion settlement
Bayer will pay up to $7.25 billion over two decades to resolve thousands of cancer claims from U.S. patients.
Settlement covers current and future lymphoma cases
Participants could receive $10,000 to $165,000 based on product use, age at diagnosis, and illness severity.
Bayer denies Roundup causes cancer
Bayer claims Roundup does not cause cancer and faces mounting litigation costs.
Supreme Court ruling impacts lawsuits
U.S. Supreme Court ruled Bayer cannot be sued in state courts for failing to warn about cancer risks.
Average payouts deemed fair by judge
St. Louis Circuit Judge Timothy Boyer called average payouts 'fair and adequate' and the total 'among the largest in mass tort history'.
Bayer's strategy to mitigate risks
Bayer CEO Bill Anderson stated the settlement is a 'decisive milestone' in reducing Roundup litigation risks.
In short
Bayer will pay up to $7.25 billion to resolve cancer claims from Roundup users, including those with non-Hodgkin lymphoma.
Read the TL;DR — this story on one card.
